Concentrix (NASDAQ:CNXC) Trading Up 8.3% – Should You Buy?

Concentrix Corporation (NASDAQ:CNXC)’s share price traded up 8.3% on Monday . The company traded as high as $23.49 and last traded at $24.0430. 175,697 shares traded hands during trading, a decline of 90% from the average session volume of 1,681,411 shares. The stock had previously closed at $22.20.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Canaccord Genuity Group cut their price target on shares of Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. Zacks Research cut shares of Concentrix from a “hold” rating to a “strong sell” rating in a report on Thursday, July 2nd. Robert W. Baird lowered their price objective on Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research report on Tuesday, June 30th. Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Finally, Bank of America reduced their target price on Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a research report on Tuesday, June 30th. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $32.75.

Concentrix Trading Up 15.0%

The firm has a market capitalization of $1.56 billion, a P/E ratio of -1.20, a price-to-earnings-growth ratio of 0.41 and a beta of 0.47. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.46. The firm’s 50-day simple moving average is $25.01 and its 200-day simple moving average is $30.99.

Concentrix (NASDAQ:CNXC) last issued its quarterly earnings results on Monday, June 29th. The company reported $2.63 EPS for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The company had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.47 billion. Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.Concentrix’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the company earned $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Analysts anticipate that Concentrix Corporation will post 9.67 EPS for the current year.

Concentrix Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 4th. Investors of record on Friday, July 24th will be paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 5.6%. The ex-dividend date of this dividend is Friday, July 24th. Concentrix’s dividend payout ratio is currently -6.75%.

Insider Buying and Selling

In other Concentrix news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the firm’s stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the sale, the insider owned 2,773,667 shares in the company, valued at $61,714,090.75. This trade represents a 68.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.90% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Concentrix

Several institutional investors have recently modified their holdings of CNXC. Geneos Wealth Management Inc. raised its holdings in shares of Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after buying an additional 522 shares in the last quarter. Larson Financial Group LLC lifted its position in Concentrix by 224.9% in the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after buying an additional 479 shares during the last quarter. Allworth Financial LP boosted its stake in Concentrix by 90.6% in the third quarter. Allworth Financial LP now owns 856 shares of the company’s stock worth $40,000 after buying an additional 407 shares in the last quarter. Global Retirement Partners LLC boosted its stake in Concentrix by 1,032.5% in the fourth quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock worth $36,000 after buying an additional 795 shares in the last quarter. Finally, Rothschild Investment LLC grew its position in Concentrix by 52.0% during the fourth quarter. Rothschild Investment LLC now owns 1,146 shares of the company’s stock valued at $48,000 after acquiring an additional 392 shares during the last quarter. 90.34% of the stock is currently owned by institutional investors.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.